Sponsored Projects Administration

Study examines reasons for delays and denials of new drugs by FDA

Published February 03, 2014 by OSP


According to a new study several potentially preventable deficiencies (such as failure to select optimal drug doses) account for significant delays in the FDA approval of new drugs.

Read More>